Aug 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher pharmaceuticals reports q2 2016 results highlighted by 32% revenue growth and $3.1 million cash from operations
* Cipher pharmaceuticals inc qtrly total revenue of $11.7 million, an increase of 32% from $8.8 million in q2 2015
* Q2 loss per share c$0.13 Source text for Eikon: ID:nCNW4XqzQa Further company coverage: CPH.TO